AGÕæÈ˹ٷ½

STOCK TITAN

[SCHEDULE 13G/A] Stoke Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Cowen Financial Products LLC
Signature:John Holmes
Name/Title:John Holmes / Chief Operating Officer
Date:07/29/2025
Stoke Therapeutics

NASDAQ:STOK

STOK Rankings

STOK Latest News

STOK Latest SEC Filings

STOK Stock Data

718.50M
52.07M
4.57%
110.19%
21.06%
Biotechnology
Pharmaceutical Preparations
United States
BEDFORD